Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Bulletin of Mathematical Biology
|
September 27, 2007
An example of model structure differences using sensitivity analyses in physiologically based pharmacokinetic models of trichloroethylene in humans
Karen A Yokley, Marina V Evans
Environmental and Molecular Mutagenesis
|
November 2, 2007
Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures
Jane C Caldwell, Nagalakshmi Keshava, Marina V Evans
Journal of Toxicology
|
December 20, 2012
State of the science: biologically based modeling in risk assessment
Jane C Caldwell, Kannan Krishnan, Marina V Evans
Journal of Toxicology
|
August 18, 2012
Cutting Edge PBPK Models and Analyses: Providing the Basis for Future Modeling Efforts and Bridges to Emerging Toxicology Paradigms
Jane C Caldwell, Marina V Evans, Kannan Krishnan
Journal of Applied Toxicology : JAT
|
June 7, 2017
A physiologically based pharmacokinetic model of vitamin D
Megan E Sawyer, Hien T Tran, Marina V Evans
Toxicology and Applied Pharmacology
|
August 8, 2009
Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach
Weihsueh A Chiu, Miles S Okino, Marina V Evans
Journal of Toxicology and Environmental Health. Part A
|
July 16, 2005
Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose
Jane Ellen Simmons, Marina V Evans, William K Boyes
Journal of Pharmacokinetics and Pharmacodynamics
|
November 3, 2004
Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism
Kristin K Isaacs, Marina V Evans, Thomas R Harris
Journal of Pharmacokinetics and Pharmacodynamics
|
November 27, 2002
Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments
Michael R Easterling, Miroslav Styblo, Marina V Evans, et al.
Environmental Health Perspectives
|
September 13, 2006
Issues in the pharmacokinetics of trichloroethylene and its metabolites
Weihsueh A Chiu, Miles S Okino, John C Lipscomb, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Bulletin of Mathematical Biology
|
September 27, 2007
An example of model structure differences using sensitivity analyses in physiologically based pharmacokinetic models of trichloroethylene in humans
Karen A Yokley, Marina V Evans
Environmental and Molecular Mutagenesis
|
November 2, 2007
Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures
Jane C Caldwell, Nagalakshmi Keshava, Marina V Evans
Journal of Toxicology
|
December 20, 2012
State of the science: biologically based modeling in risk assessment
Jane C Caldwell, Kannan Krishnan, Marina V Evans
Journal of Toxicology
|
August 18, 2012
Cutting Edge PBPK Models and Analyses: Providing the Basis for Future Modeling Efforts and Bridges to Emerging Toxicology Paradigms
Jane C Caldwell, Marina V Evans, Kannan Krishnan
Journal of Applied Toxicology : JAT
|
June 7, 2017
A physiologically based pharmacokinetic model of vitamin D
Megan E Sawyer, Hien T Tran, Marina V Evans
Toxicology and Applied Pharmacology
|
August 8, 2009
Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach
Weihsueh A Chiu, Miles S Okino, Marina V Evans
Journal of Toxicology and Environmental Health. Part A
|
July 16, 2005
Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose
Jane Ellen Simmons, Marina V Evans, William K Boyes
Journal of Pharmacokinetics and Pharmacodynamics
|
November 3, 2004
Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism
Kristin K Isaacs, Marina V Evans, Thomas R Harris
Journal of Pharmacokinetics and Pharmacodynamics
|
November 27, 2002
Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments
Michael R Easterling, Miroslav Styblo, Marina V Evans, et al.
Environmental Health Perspectives
|
September 13, 2006
Issues in the pharmacokinetics of trichloroethylene and its metabolites
Weihsueh A Chiu, Miles S Okino, John C Lipscomb, et al.
Page
of 3